These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4698131)

  • 1. Volume-dependent essential and steroid hypertension.
    Dustan HP; Bravo EL; Tarazi RC
    Am J Cardiol; 1973 May; 31(5):606-15. PubMed ID: 4698131
    [No Abstract]   [Full Text] [Related]  

  • 2. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL; Dustan HP; Tarazi RC
    Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K; Morimoto S; Takeda R; Murakami M
    Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyporeninemic hypertension.
    Crane MG; Harris JJ; Johns VJ
    Am J Med; 1972 Apr; 52(4):457-66. PubMed ID: 5017240
    [No Abstract]   [Full Text] [Related]  

  • 5. Spironolactone and triamterene in volume-dependent essential hypertension.
    DeCarvalho JG; Emery AC; Frohlich ED
    Clin Pharmacol Ther; 1980 Jan; 27(1):53-6. PubMed ID: 6985854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 46-year-old man with treatment-resistant hypertension.
    Orme NM; Hart PA; Mauck KF
    Mayo Clin Proc; 2010 Oct; 85(10):e70-3. PubMed ID: 20884821
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 8. Aldosteronism in hypertension. The spironolactone response test.
    Spark RF; Melby JC
    Ann Intern Med; 1968 Oct; 69(4):685-91. PubMed ID: 5682243
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study on the renin-angiotensin-aldosterone system. Effects of sodium restriction and postural changes on plasma renin activity and fluctuation in urinary aldosterone].
    Kubota K
    Jpn Circ J; 1969 Mar; 33(3):323-32. PubMed ID: 4307397
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1006-13. PubMed ID: 4298942
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
    Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of aldosterone-induced hypertension in man.
    Distler A; Just HJ; Philipp T
    Clin Sci Mol Med; 1973 Dec; 45(6):743-50. PubMed ID: 4760033
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrence of hypertension in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumes.
    Wenting GJ; Man in 't Veld AJ; Derkx FH; Schalekamp MA
    Clin Exp Hypertens A; 1982; 4(9-10):1727-48. PubMed ID: 6754151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of studying essential arterial hypertension with isotopic methods. Their application in arterial hypertension with low renin level].
    Olmer M; Salvadori JM; Paulin R; Sommer A; Marion J
    Nouv Presse Med; 1974 Feb; 3(5):233-6. PubMed ID: 4819942
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
    Klump F; Braun B; Klaus D; Lemke R; Zehner J; Zöfel P
    Dtsch Med Wochenschr; 1975 Mar; 100(12):577-84. PubMed ID: 1168122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential hypertension.
    Acchiardo S; Dustan HP; Tarazi RC
    Cleve Clin Q; 1972; 39(4):153-62. PubMed ID: 4660197
    [No Abstract]   [Full Text] [Related]  

  • 17. [Idiopathic edemas with secondary hyperaldosteronism. Definition, history, pathogenesis].
    Veyrat R
    J Urol Nephrol (Paris); 1970 Dec; 76(12):969-84. PubMed ID: 5511433
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased plasma renin activity, secondary aldosteronism, and hypertension.
    Chauvel PJ; Beveridge J; Stokes GS
    Am J Dis Child; 1970 Feb; 119(2):159-63. PubMed ID: 5410567
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.
    Margolius HS; Horwitz D; Pisano JJ; Keiser HR
    Circ Res; 1974 Dec; 35(6):820-5. PubMed ID: 4430079
    [No Abstract]   [Full Text] [Related]  

  • 20. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.